Everything about Hemgenix
Range of suitable patients: CDEC mentioned the uncertainty in the amount of individuals with moderately severe to severe hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical authorities consulted by CADTH indicated that some individuals who will be categorised as obtaining gentle or moderate illness might have a serious bleeding